Clinical Pharmacology - Chemical - Modeling and Simulation

(W0930-11-63) Biorelevant Dissolution and PBPK Modelling to Forecast Oral Absorption – Enabling Formulations for Corallopyronin A

(T0930-11-64) Cost-Effective Strategy - An Innovative Approach Assessing the Drifting Bioavailability of Fixed-Dose Combination Formulations

(W0930-11-64) Using PBPK Modeling in Risk-Assessment of Abuse-Deterrent Formulations

(M0930-11-65) A Mechanistic PBPK Model for Maraviroc to Elucidate the Dose Related Non-Linearity in Oral Absorption using a Middle-Out Approach

(M1130-11-63) Physiologically Based Pharmacokinetic (PBPK) Modelling of Cabotegravir to Evaluate the Feasibility of Drug Delivery via Microarray Patches for the Treatment of HIV in Children

(M1130-11-64) Assessing the Impact of Excipient and Food Intake on Bioequivalence Using PBPK and Virtual Bioequivalence Trial: A Case Example with Acyclovir Immediate Release Tablets

(T1130-11-64) Physiologically Based Pharmacokinetic Modelling to Predict the Pharmacokinetics of Aspirin and Its Metabolite Salicylic Acid after Intravenous, Oral, and Rectal Administration

(T1330-11-64) Physiologically Based Pharmacokinetic Model for Miltefosine in Mice

(M1330-11-64) Prediction Accuracy of Allometrically Scaled VLX-1005 Pharmacokinetics

(T1530-11-61) Physiologically-Based Pharmacokinetic Model to Predict Milk Drug Concentrations of Breast Cancer Resistance Protein Substrates

(T1530-11-62) Effect of Intestinal Precipitation on Cinnarizine Plasma Profile in Fasted State Employing Biorelevant In Vitro Tools and GastroPlus^® Modeling